Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing Niu

Showing results (191-200 of 225) with videos related to

Pageof 23
Sort By:
Angewandte Chemie (International Ed. in English)|July 11, 2020
Non-Interpenetrated Single-Crystal Covalent Organic FrameworksLin Liang, Yi Qiu, Wei David Wang, et al.
BMJ Open|July 13, 2013
Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trialXingshun Qi, Chuangye He, Zhanxin Yin, et al.
Scientific Reports|February 3, 2016
The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial ChemoembolizationLei Liu, Yan Zhao, Jia Jia, et al.
Radiology|July 7, 2017
Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with CirrhosisYong Lv, Chuangye He, Zhengyu Wang, et al.
Journal of the American Chemical Society|August 21, 2025
<i>De Novo</i> Structure Determination of Covalent Organic Frameworks by NMR CrystallographyZhi-Peng Wang, Si-Min Yu, Guan-Le Chen, et al.
The American Journal of Gastroenterology|December 9, 2021
Correction to: Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational StudyYong Lv, Wei Bai, Kai Li, et al.
The American Journal of Gastroenterology|February 25, 2021
Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational StudyYong Lv, Wei Bai, Kai Li, et al.
American Journal of Translational Research|May 22, 2026
Genetically prioritized plasma proteins in intracerebral hemorrhage identified by Mendelian randomization with functional evidence of neuronal vulnerabilityHeng Gu, Yan-Song Bu, Jing-Jing Niu, et al.
Academic Radiology|August 5, 2018
Motor Cortex Mapping in Patients With Hepatic Myelopathy After Transjugular Intrahepatic Portosystemic ShuntLong-Biao Cui, Shuyao Ren, Yi-Bin Xi, et al.
World Journal of Gastroenterology|May 1, 2020
Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolizationZhe-Xuan Wang, Jing Li, En-Xin Wang, et al.
Pageof 23

Showing results (191-200 of 225) with videos related to

Sort By:
Pageof 23
Angewandte Chemie (International Ed. in English)|July 11, 2020
Non-Interpenetrated Single-Crystal Covalent Organic FrameworksLin Liang, Yi Qiu, Wei David Wang, et al.
BMJ Open|July 13, 2013
Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trialXingshun Qi, Chuangye He, Zhanxin Yin, et al.
Scientific Reports|February 3, 2016
The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial ChemoembolizationLei Liu, Yan Zhao, Jia Jia, et al.
Radiology|July 7, 2017
Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with CirrhosisYong Lv, Chuangye He, Zhengyu Wang, et al.
Journal of the American Chemical Society|August 21, 2025
<i>De Novo</i> Structure Determination of Covalent Organic Frameworks by NMR CrystallographyZhi-Peng Wang, Si-Min Yu, Guan-Le Chen, et al.
The American Journal of Gastroenterology|December 9, 2021
Correction to: Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational StudyYong Lv, Wei Bai, Kai Li, et al.
The American Journal of Gastroenterology|February 25, 2021
Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational StudyYong Lv, Wei Bai, Kai Li, et al.
American Journal of Translational Research|May 22, 2026
Genetically prioritized plasma proteins in intracerebral hemorrhage identified by Mendelian randomization with functional evidence of neuronal vulnerabilityHeng Gu, Yan-Song Bu, Jing-Jing Niu, et al.
Academic Radiology|August 5, 2018
Motor Cortex Mapping in Patients With Hepatic Myelopathy After Transjugular Intrahepatic Portosystemic ShuntLong-Biao Cui, Shuyao Ren, Yi-Bin Xi, et al.
World Journal of Gastroenterology|May 1, 2020
Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolizationZhe-Xuan Wang, Jing Li, En-Xin Wang, et al.
Pageof 23